High-intensity focused ultrasound in the treatment of prostatic disease

Richard Foster, Richard Bihrle, N. T. Sanghvi, F. J. Fry, J. P. Donohue

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Beginning in 1987, high-intensity focused ultrasound was investigated experimentally in a canine model to determine whether or not prostate tissue could be destroyed with good aiming and control. Subsequently a transrectal probe was developed and used to treat canine prostates in a formal study to determine whether or not this technology could be used to treat human benign prostatic hypertrophy. Next, after FDA approval, 15 patients were treated at Indiana University in the fall of 1992. Both canine and human studies have shown that high-intensity focused ultrasound administered via a transrectal probe is capable of creating prostate lesions without injury to intervening and surrounding tissue.

Original languageEnglish
Pages (from-to)29-33
Number of pages5
JournalEuropean Urology
Volume23
Issue numberSUPPL. 1
StatePublished - 1993

Fingerprint

Prostatic Diseases
Canidae
Prostate
Prostatic Hyperplasia
Therapeutics
Technology
Wounds and Injuries

Keywords

  • High-intensity focused ultrasound
  • Prostate

ASJC Scopus subject areas

  • Urology

Cite this

Foster, R., Bihrle, R., Sanghvi, N. T., Fry, F. J., & Donohue, J. P. (1993). High-intensity focused ultrasound in the treatment of prostatic disease. European Urology, 23(SUPPL. 1), 29-33.

High-intensity focused ultrasound in the treatment of prostatic disease. / Foster, Richard; Bihrle, Richard; Sanghvi, N. T.; Fry, F. J.; Donohue, J. P.

In: European Urology, Vol. 23, No. SUPPL. 1, 1993, p. 29-33.

Research output: Contribution to journalArticle

Foster, R, Bihrle, R, Sanghvi, NT, Fry, FJ & Donohue, JP 1993, 'High-intensity focused ultrasound in the treatment of prostatic disease', European Urology, vol. 23, no. SUPPL. 1, pp. 29-33.
Foster, Richard ; Bihrle, Richard ; Sanghvi, N. T. ; Fry, F. J. ; Donohue, J. P. / High-intensity focused ultrasound in the treatment of prostatic disease. In: European Urology. 1993 ; Vol. 23, No. SUPPL. 1. pp. 29-33.
@article{266af5653f284a13af20ecda134cf9e1,
title = "High-intensity focused ultrasound in the treatment of prostatic disease",
abstract = "Beginning in 1987, high-intensity focused ultrasound was investigated experimentally in a canine model to determine whether or not prostate tissue could be destroyed with good aiming and control. Subsequently a transrectal probe was developed and used to treat canine prostates in a formal study to determine whether or not this technology could be used to treat human benign prostatic hypertrophy. Next, after FDA approval, 15 patients were treated at Indiana University in the fall of 1992. Both canine and human studies have shown that high-intensity focused ultrasound administered via a transrectal probe is capable of creating prostate lesions without injury to intervening and surrounding tissue.",
keywords = "High-intensity focused ultrasound, Prostate",
author = "Richard Foster and Richard Bihrle and Sanghvi, {N. T.} and Fry, {F. J.} and Donohue, {J. P.}",
year = "1993",
language = "English",
volume = "23",
pages = "29--33",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "SUPPL. 1",

}

TY - JOUR

T1 - High-intensity focused ultrasound in the treatment of prostatic disease

AU - Foster, Richard

AU - Bihrle, Richard

AU - Sanghvi, N. T.

AU - Fry, F. J.

AU - Donohue, J. P.

PY - 1993

Y1 - 1993

N2 - Beginning in 1987, high-intensity focused ultrasound was investigated experimentally in a canine model to determine whether or not prostate tissue could be destroyed with good aiming and control. Subsequently a transrectal probe was developed and used to treat canine prostates in a formal study to determine whether or not this technology could be used to treat human benign prostatic hypertrophy. Next, after FDA approval, 15 patients were treated at Indiana University in the fall of 1992. Both canine and human studies have shown that high-intensity focused ultrasound administered via a transrectal probe is capable of creating prostate lesions without injury to intervening and surrounding tissue.

AB - Beginning in 1987, high-intensity focused ultrasound was investigated experimentally in a canine model to determine whether or not prostate tissue could be destroyed with good aiming and control. Subsequently a transrectal probe was developed and used to treat canine prostates in a formal study to determine whether or not this technology could be used to treat human benign prostatic hypertrophy. Next, after FDA approval, 15 patients were treated at Indiana University in the fall of 1992. Both canine and human studies have shown that high-intensity focused ultrasound administered via a transrectal probe is capable of creating prostate lesions without injury to intervening and surrounding tissue.

KW - High-intensity focused ultrasound

KW - Prostate

UR - http://www.scopus.com/inward/record.url?scp=0027298585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027298585&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 29

EP - 33

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - SUPPL. 1

ER -